Improving statistical learning methods via features selection without replacement sampling and random projection
Authors:
Sulaiman khan,
Muhammad Ahmad,
Fida Ullah,
Carlos Aguilar Ibañez,
José Eduardo Valdez Rodriguez
Abstract:
Cancer is fundamentally a genetic disease characterized by genetic and epigenetic alterations that disrupt normal gene expression, leading to uncontrolled cell growth and metastasis. High-dimensional microarray datasets pose challenges for classification models due to the "small n, large p" problem, resulting in overfitting. This study makes three different key contributions: 1) we propose a machi…
▽ More
Cancer is fundamentally a genetic disease characterized by genetic and epigenetic alterations that disrupt normal gene expression, leading to uncontrolled cell growth and metastasis. High-dimensional microarray datasets pose challenges for classification models due to the "small n, large p" problem, resulting in overfitting. This study makes three different key contributions: 1) we propose a machine learning-based approach integrating the Feature Selection Without Re-placement (FSWOR) technique and a projection method to improve classification accuracy. 2) We apply the Kendall statistical test to identify the most significant genes from the brain cancer mi-croarray dataset (GSE50161), reducing the feature space from 54,675 to 20,890 genes.3) we apply machine learning models using k-fold cross validation techniques in which our model incorpo-rates ensemble classifiers with LDA projection and Naïve Bayes, achieving a test score of 96%, outperforming existing methods by 9.09%. The results demonstrate the effectiveness of our ap-proach in high-dimensional gene expression analysis, improving classification accuracy while mitigating overfitting. This study contributes to cancer biomarker discovery, offering a robust computational method for analyzing microarray data.
△ Less
Submitted 28 May, 2025;
originally announced June 2025.
ACEGEN: Reinforcement learning of generative chemical agents for drug discovery
Authors:
Albert Bou,
Morgan Thomas,
Sebastian Dittert,
Carles Navarro Ramírez,
Maciej Majewski,
Ye Wang,
Shivam Patel,
Gary Tresadern,
Mazen Ahmad,
Vincent Moens,
Woody Sherman,
Simone Sciabola,
Gianni De Fabritiis
Abstract:
In recent years, reinforcement learning (RL) has emerged as a valuable tool in drug design, offering the potential to propose and optimize molecules with desired properties. However, striking a balance between capabilities, flexibility, reliability, and efficiency remains challenging due to the complexity of advanced RL algorithms and the significant reliance on specialized code. In this work, we…
▽ More
In recent years, reinforcement learning (RL) has emerged as a valuable tool in drug design, offering the potential to propose and optimize molecules with desired properties. However, striking a balance between capabilities, flexibility, reliability, and efficiency remains challenging due to the complexity of advanced RL algorithms and the significant reliance on specialized code. In this work, we introduce ACEGEN, a comprehensive and streamlined toolkit tailored for generative drug design, built using TorchRL, a modern RL library that offers thoroughly tested reusable components. We validate ACEGEN by benchmarking against other published generative modeling algorithms and show comparable or improved performance. We also show examples of ACEGEN applied in multiple drug discovery case studies. ACEGEN is accessible at \url{https://github.com/acellera/acegen-open} and available for use under the MIT license.
△ Less
Submitted 22 July, 2024; v1 submitted 7 May, 2024;
originally announced May 2024.
